Showing results (161-170 of 767) with videos related to
Sort By:
Pageof 77
The Gerontologist|August 13, 2014
Successful aging and subjective well-being among oldest-old adultsJinmyoung Cho, Peter Martin, Leonard W Poon, et al.Journal of Aging Research|August 18, 2012
The older they are, the less successful they become? Findings from the georgia centenarian studyJinmyoung Cho, Peter Martin, Leonard W PoonClinical Lymphoma, Myeloma & Leukemia|April 19, 2020
Management of Adverse Events From the Combination of Rituximab and Lenalidomide in the Treatment of Patients With Follicular and Low-Grade Non-Hodgkin LymphomaBruce D Cheson, Franck Morschhauser, Peter MartinDisaster Medicine and Public Health Preparedness|September 8, 2023
Communication in Sudden-Onset Major Incidents: Patterns and Challenges-Scoping ReviewPeter Martin Hansen, Søren Mikkelsen, Marius RehnGround Water|June 4, 2011
Hybrid-optimization algorithm for the management of a conjunctive-use project and well field designYung-Chia Chiu, Tracy Nishikawa, Peter MartinJournal of Clinical Neuromuscular Disease|August 25, 2015
Correlation of Changes in Gait Parameters, With Phenotype, Outcome Measures, and Electrodiagnostic Abnormalities in a Patient With Anti-MAG Neuropathy After Exacerbation and ImprovementMary L Vo, Peter Martin, Norman LatovClinical & Experimental Ophthalmology|April 22, 2006
Idiopathic orbital inflammation with sclerosing mesenteritis: a new association?Vidushi Sharma, Peter Martin, Veli-Matti MarjoniemiJournal of Clinical Medicine|October 16, 2024
Streamlined Preoperative Iron Deficiency Screening and IV Treatment for Colorectal Cancer Patients beyond Clinical TrialsCaroline Erichsen, Victoria Rosberg, Peter-Martin KrarupCancer|October 15, 2008
Durable complete responses from therapy with combined epratuzumab and rituximab: final results from an international multicenter, phase 2 study in recurrent, indolent, non-Hodgkin lymphomaJohn P Leonard, Stephen J Schuster, Christos Emmanouilides, et al.The New England Journal of Medicine|November 5, 2010
Brentuximab vedotin (SGN-35) for relapsed CD30-positive lymphomasAnas Younes, Nancy L Bartlett, John P Leonard, et al.Pageof 77